Your browser doesn't support javascript.
loading
Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling.
Reyes, Luis F; Restrepo, Marcos I; Hinojosa, Cecilia A; Soni, Nilam J; Anzueto, Antonio; Babu, Bettina L; Gonzalez-Juarbe, Norberto; Rodriguez, Alejandro H; Jimenez, Alejandro; Chalmers, James D; Aliberti, Stefano; Sibila, Oriol; Winter, Vicki T; Coalson, Jacqueline J; Giavedoni, Luis D; Dela Cruz, Charles S; Waterer, Grant W; Witzenrath, Martin; Suttorp, Norbert; Dube, Peter H; Orihuela, Carlos J.
Afiliação
  • Reyes LF; 1 Division of Pulmonary Diseases and Critical Care Medicine.
  • Restrepo MI; 2 Division of Pulmonary Diseases and Critical Care Medicine, South Texas Veterans Health Care System, San Antonio, Texas.
  • Hinojosa CA; 1 Division of Pulmonary Diseases and Critical Care Medicine.
  • Soni NJ; 2 Division of Pulmonary Diseases and Critical Care Medicine, South Texas Veterans Health Care System, San Antonio, Texas.
  • Anzueto A; 1 Division of Pulmonary Diseases and Critical Care Medicine.
  • Babu BL; 2 Division of Pulmonary Diseases and Critical Care Medicine, South Texas Veterans Health Care System, San Antonio, Texas.
  • Gonzalez-Juarbe N; 1 Division of Pulmonary Diseases and Critical Care Medicine.
  • Rodriguez AH; 2 Division of Pulmonary Diseases and Critical Care Medicine, South Texas Veterans Health Care System, San Antonio, Texas.
  • Jimenez A; 1 Division of Pulmonary Diseases and Critical Care Medicine.
  • Chalmers JD; 2 Division of Pulmonary Diseases and Critical Care Medicine, South Texas Veterans Health Care System, San Antonio, Texas.
  • Aliberti S; 1 Division of Pulmonary Diseases and Critical Care Medicine.
  • Sibila O; 2 Division of Pulmonary Diseases and Critical Care Medicine, South Texas Veterans Health Care System, San Antonio, Texas.
  • Winter VT; 3 Department of Microbiology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
  • Coalson JJ; 4 Critical Care Medicine, Hospital Universitari de Tarragona Joan XXIII, Rovira i Virgili University, Tarragona, Spain.
  • Giavedoni LD; 5 Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Tarragona, Spain.
  • Dela Cruz CS; 6 Cardiovascular Medicine, Heart & Vascular Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates.
  • Waterer GW; 7 School of Medicine, University of Dundee, Dundee, United Kingdom.
  • Witzenrath M; 8 Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Suttorp N; 9 Cardio-thoracic Unit and Adult Cystic Fibrosis Centre, Milan, Italy.
  • Dube PH; 10 Istituti di Ricovero e Cura a Carattere Scientifico, Granada Ospedale Maggiore Policlinico, Milan, Italy.
  • Orihuela CJ; 11 Division of Pulmonary Diseases, Department of Medicine, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
Am J Respir Crit Care Med ; 196(5): 609-620, 2017 09 01.
Article em En | MEDLINE | ID: mdl-28614669
ABSTRACT
RATIONALE Up to one-third of patients hospitalized with pneumococcal pneumonia experience major adverse cardiac events (MACE) during or after pneumonia. In mice, Streptococcus pneumoniae can invade the myocardium, induce cardiomyocyte death, and disrupt cardiac function following bacteremia, but it is unknown whether the same occurs in humans with severe pneumonia.

OBJECTIVES:

We sought to determine whether S. pneumoniae can (1) translocate the heart, (2) induce cardiomyocyte death, (3) cause MACE, and (4) induce cardiac scar formation after antibiotic treatment during severe pneumonia using a nonhuman primate (NHP) model.

METHODS:

We examined cardiac tissue from six adult NHPs with severe pneumococcal pneumonia and three uninfected control animals. Three animals were rescued with antibiotics (convalescent animals). Electrocardiographic, echocardiographic, and serum biomarkers of cardiac damage were measured (troponin T, N-terminal pro-brain natriuretic peptide, and heart-type fatty acid binding protein). Histological examination included hematoxylin and eosin staining, immunofluorescence, immunohistochemistry, picrosirius red staining, and transmission electron microscopy. Immunoblots were used to assess the underlying mechanisms. MEASUREMENTS AND MAIN

RESULTS:

Nonspecific ischemic alterations were detected by electrocardiography and echocardiography. Serum levels of troponin T and heart-type fatty acid binding protein were increased (P < 0.05) after pneumococcal infection in both acutely ill and convalescent NHPs. S. pneumoniae was detected in the myocardium of all NHPs with acute severe pneumonia. Necroptosis and apoptosis were detected in the myocardium of both acutely ill and convalescent NHPs. Evidence of cardiac scar formation was observed only in convalescent animals by transmission electron microscopy and picrosirius red staining.

CONCLUSIONS:

S. pneumoniae invades the myocardium and induces cardiac injury with necroptosis and apoptosis, followed by cardiac scarring after antibiotic therapy, in an NHP model of severe pneumonia.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article